OTCMKTS:AVXT AVAX Technologies (AVXT) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free AVXT Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get AVAX Technologies alerts: Email Address Ad Porter & CompanyTrump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. About AVAX Technologies Stock (OTCMKTS:AVXT)AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. The company's product candidates that have completed phase II clinical trials include M-VAX for the treatment of melanoma and O-VAX for the treatment for ovarian cancer. It also develops LungVax for the treatment of non-small cell lung cancer. The company was formerly known as Walden Laboratories, Inc. and changed its name to AVAX Technologies, Inc. in March 1996. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.Read More Ad Porter & CompanyTrump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. AVXT Stock News HeadlinesApril 28, 2024 | nasdaq.comAvalanche Price Forecast: Can AVAX Hit $50 in the Week Ahead?April 27, 2024 | msn.comAVAX's tough year - What needs to change for Avalanche?May 1, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.April 17, 2024 | finance.yahoo.comAvalanche USD (AVAX-USD) Interactive Price Chart - Yahoo FinanceApril 16, 2024 | forbes.comHow To Buy Avalanche (AVAX)April 11, 2024 | msn.comAVAX gone wrong - Why is it suddenly out of the top 10?April 9, 2024 | msn.comNeed The Next Mooner? NUGX Presale Is Huge Underpriced While AVAX And BCH Investors Buy InMarch 26, 2024 | tmcnet.comAvaxTech Passes SolidProof Smart Contract Audit, Enhancing Safety for Avax InvestorsMay 1, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.March 8, 2024 | msn.comAvalanche (AVAX) 2030 Price Prediction: Bull, Bear, and Base ForecastsFebruary 6, 2024 | fool.comAvalanche (CRYPTO: AVAX)September 30, 2023 | finance.yahoo.comJ&P-Avax SA. (ATH:AVAX): Risks You Need To Consider Before BuyingSeptember 26, 2023 | investing.comAVAX/EUR - Avalanche EuroSeptember 13, 2023 | investing.comAVAX/BRL Binance Technical AnalysisSeptember 9, 2023 | finance.yahoo.comAvax S.A. (AVAX.AT)September 5, 2023 | investing.comAVAX/BTC Binance Technical AnalysisAugust 7, 2023 | finance.yahoo.comAVXT - AVAX Technologies, Inc.May 19, 2023 | investing.comAVAX/CAD Synthetic Technical AnalysisMay 8, 2023 | investing.comAVAX/BTC - Avalanche BitcoinMarch 31, 2023 | fxstreet.comThese altcoins could yield massive gains in the short term: FTM, ADA and AVAXMarch 18, 2023 | fxstreet.comCryptocurrencies Price Prediction: Chainlink, AVAX & Ethereum – American Wrap 16 MarchMarch 18, 2023 | fxstreet.comThis is why AVAX price is looking at a 25% rise despite crashing below $16February 26, 2023 | fxstreet.comAVAX Price Prediction: Despite an almost 10% crash, Avalanche shows optimistic signalsFebruary 12, 2023 | investing.comAVAX/CAD - Avalanche Canadian DollarJanuary 9, 2023 | fxstreet.comIs AVAX price headed for a crash after registering a 12% rally this week?October 10, 2022 | investing.comAVAX/USD Binance Technical AnalysisOctober 2, 2022 | forbes.com3X long for AVAX (AVAX3L)See More Headlines Receive AVXT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVAX Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:AVXT CUSIPN/A CIKN/A Webwww.avax-tech.com Phone(215) 241-9760Fax215-241-9684Employees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesAdele SommerfeldChief Executive Officer & DirectorKey CompetitorsAdvanced Life SciencesOTCMKTS:ADLSAlvotechNYSE:ALVOEnzon PharmaceuticalsOTCMKTS:ENZNNeurobiological TechnologiesOTCMKTS:NTIIOmni Bio PharmaceuticalOTCMKTS:OMBPView All Competitors AVXT Stock Analysis - Frequently Asked Questions How do I buy shares of AVAX Technologies? Shares of AVXT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:AVXT) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump’s last act as President Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing4 Cryptos BETTER than BitcoinTrue Market InsidersThe only accurate crypto trading system I know …Weiss RatingsGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVAX Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
